These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 19483042)
1. Your racing horses will help you to quit: a lesson for COPD and alpha1-antitrypsin deficiency research. Soriano JB; Miravitlles M Eur Respir J; 2009 Jun; 33(6):1244-6. PubMed ID: 19483042 [No Abstract] [Full Text] [Related]
2. Alpha one antitrypsin deficiency: from gene to treatment. Wood AM; Stockley RA Respiration; 2007; 74(5):481-92. PubMed ID: 17671403 [TBL] [Abstract][Full Text] [Related]
3. Rate of progression of lung function impairment in alpha1-antitrypsin deficiency. Dawkins PA; Dawkins CL; Wood AM; Nightingale PG; Stockley JA; Stockley RA Eur Respir J; 2009 Jun; 33(6):1338-44. PubMed ID: 19164359 [TBL] [Abstract][Full Text] [Related]
9. Quality of life measured by the St George's Respiratory Questionnaire and spirometry. Weatherall M; Marsh S; Shirtcliffe P; Williams M; Travers J; Beasley R Eur Respir J; 2009 May; 33(5):1025-30. PubMed ID: 19164350 [TBL] [Abstract][Full Text] [Related]
10. Pulmonary Physiology of Chronic Obstructive Pulmonary Disease, Cystic Fibrosis, and Alpha-1 Antitrypsin Deficiency. Stockley JA; Stockley RA Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S118-22. PubMed ID: 27115945 [TBL] [Abstract][Full Text] [Related]
11. The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression. Wise RA Am J Med; 2006 Oct; 119(10 Suppl 1):4-11. PubMed ID: 16996894 [TBL] [Abstract][Full Text] [Related]
12. Exacerbations in subjects with alpha-1 antitrypsin deficiency receiving augmentation therapy. Campos MA; Alazemi S; Zhang G; Wanner A; Salathe M; Baier H; Sandhaus RA Respir Med; 2009 Oct; 103(10):1532-9. PubMed ID: 19464158 [TBL] [Abstract][Full Text] [Related]
13. The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort. Casanova C; de Torres JP; Aguirre-Jaíme A; Pinto-Plata V; Marin JM; Cordoba E; Baz R; Cote C; Celli BR Am J Respir Crit Care Med; 2011 Nov; 184(9):1015-21. PubMed ID: 21836135 [TBL] [Abstract][Full Text] [Related]
14. The protease inhibitor PI*S allele and COPD: a meta-analysis. Dahl M; Hersh CP; Ly NP; Berkey CS; Silverman EK; Nordestgaard BG Eur Respir J; 2005 Jul; 26(1):67-76. PubMed ID: 15994391 [TBL] [Abstract][Full Text] [Related]
15. A review of alpha-1 antitrypsin deficiency. Ranes J; Stoller JK Semin Respir Crit Care Med; 2005 Apr; 26(2):154-66. PubMed ID: 16088434 [TBL] [Abstract][Full Text] [Related]
16. The Impact of Delayed Diagnosis of Alpha-1 Antitrypsin Deficiency: The Association Between Diagnostic Delay and Worsened Clinical Status. Tejwani V; Nowacki AS; Fye E; Sanders C; Stoller JK Respir Care; 2019 Aug; 64(8):915-922. PubMed ID: 30914495 [TBL] [Abstract][Full Text] [Related]
17. Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD. Fan VS; Ramsey SD; Make BJ; Martinez FJ COPD; 2007 Mar; 4(1):29-39. PubMed ID: 17364675 [TBL] [Abstract][Full Text] [Related]
18. [The importance of the at risk COPD patients (Stage 0) and clinical differences]. Kömüs N; Tertemiz KC; Sevinç C Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073 [TBL] [Abstract][Full Text] [Related]
19. [Therapeutic goals and outcome measurements in COPD patients]. Morr H Med Klin (Munich); 2006 Apr; 101(4):279-82. PubMed ID: 16607483 [TBL] [Abstract][Full Text] [Related]
20. A 56-year-old woman with mixed obstructive and restrictive lung disease. Khan SU; Kavuru MS Respir Care; 2000 May; 45(5):533-4. PubMed ID: 10813230 [No Abstract] [Full Text] [Related] [Next] [New Search]